Validating in vivo quantification of tau with [18F]AV-1451 PET

Trial Profile

Validating in vivo quantification of tau with [18F]AV-1451 PET

Phase of Trial: Phase II

Latest Information Update: 30 Nov 2016

At a glance

  • Drugs Flortaucipir-F-18 (Primary)
  • Indications Alzheimer's disease
  • Focus Diagnostic use
  • Acronyms TRT-tau
  • Most Recent Events

    • 30 Nov 2016 Planned End Date changed from 16 May 2017 to 16 May 2018.
    • 30 Nov 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top